FDA greenlights momelotinib (Ojjaara) as the exclusive treatment for myelofibrosis patients battling anemia

Ann Med Surg (Lond). 2024 Oct 23;86(12):6916-6917. doi: 10.1097/MS9.0000000000002690. eCollection 2024 Dec.

Authors

Memuna Jehanzeb¹, Urooj Iqbal², Neha Farhat³, Radeyah Waseem², Maryam Shahzad², Mohammed Mahmmoud Fadelallah Eljack⁴

Affiliations

¹ Ayub Medical College, Abbottabad, Pakistan.
² Dow University of Health Sciences, Karachi, Pakistan.
³ Karachi Medical and Dental College, Karachi, Pakistan.
⁴ Faculty of Medicine and Health Sciences, University of Bakht Alruda, Ad Duwaym, Sudan.

No abstract available

Publication types

Editorial